Crohn’s disease recurrence updates: first surgery vs. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors

Background and aims Crohn’s disease (CD) pathogenesis is still unclear. Remodeling in mucosal microbiota and systemic immunoregulation may represent an important component in tissue injury. Here, we aim to characterize the ileal microbiota in both pathological and healthy settings and to evaluate the correlated systemic microbial-associated inflammatory markers comparing first-time surgery and relapse clinical conditions. Methods We enrolled 28 CD patients at surgery; we collected inflamed and non-inflamed mucosa tissues and blood samples from each patient. Bacterial wall adherence was observed histologically, while its composition was assessed through amplicon sequencing of the 16S rRNA gene. In addition, we evaluated the systemic microRNA (miRNA) using quantitative real-time PCR amplification and free fatty acids (FFAs) using gas chromatography–mass spectroscopy. Results The total number of mucosal adherent microbiota was enriched in healthy compared to inflamed mucosa. In contrast, the phylum Tenericutes, the family Ruminococcaceae, and the genera Mesoplasma and Mycoplasma were significantly enriched in the pathological setting. Significant microbiota differences were observed between the relapse and first surgery patients regarding the families Bacillaceae 2 and Brucellaceae and the genera Escherichia/Shigella, Finegoldia, Antrobacter, Gemmatimonas, Moraxella, Anoxibacillus, and Proteus. At the systemic level, we observed a significant downregulation of circulating miR-155 and miR-223, as well as 2-methyl butyric, isobutyric, and hexanoic (caproic) acids in recurrence compared to the first surgery patients. In addition, the level of hexanoic acid seems to act as a predictor of recurrence risk in CD patients (OR 18; 95% confidence interval 1.24–261.81; p = 0.006). Conclusions We describe a dissimilarity of ileal microbiota composition comparing CD and healthy settings, as well as systemic microbial-associated inflammatory factors between first surgery and surgical relapse. We suggest that patterns of microbiota, associated with healthy ileal tissue, could be involved in triggering CD recurrence. Our findings may provide insight into the dynamics of the gut microbiota–immunity axis in CD surgical recurrence, paving the way for new diagnostics and therapeutics aimed not only at reducing inflammation but also at maintaining a general state of eubiosis in healthy tissue.

[1]  J. Forment,et al.  Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications , 2021, Clinical and translational gastroenterology.

[2]  F. Stingo,et al.  Free Fatty Acids Signature in Human Intestinal Disorders: Significant Association between Butyric Acid and Celiac Disease , 2021, Nutrients.

[3]  A. Amedei,et al.  Diving into inflammation: a pilot study exploring the dynamics of the immune-microbiota axis in ileal tissue layers of patients with Crohn's disease. , 2021, Journal of Crohn's & colitis.

[4]  R. Słomski,et al.  Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study , 2021, Scientific reports.

[5]  Keli Yang,et al.  Elucidation of Proteus mirabilis as a Key Bacterium in Crohn's Disease Inflammation. , 2020, Gastroenterology.

[6]  Xujun Zhang,et al.  MicroRNAs Regulate Intestinal Immunity and Gut Microbiota for Gastrointestinal Health: A Comprehensive Review , 2020, Genes.

[7]  Junping Wang,et al.  IL-21 mediates microRNA-423-5p /claudin-5 signal pathway and intestinal barrier function in inflammatory bowel disease , 2020, Aging.

[8]  M. Cybulski,et al.  Elevated miRNA Inversely Correlates with E-cadherin Gene Expression in Tissue Biopsies from Crohn Disease Patients in contrast to Ulcerative Colitis Patients , 2020, BioMed research international.

[9]  E. Elinav,et al.  Interaction between microbiota and immunity in health and disease , 2020, Cell Research.

[10]  F. Caprioli,et al.  The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation , 2020, Cells.

[11]  R. Fani,et al.  Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer , 2020, bioRxiv.

[12]  C. Manichanh,et al.  Early Postoperative Endoscopic Recurrence in Crohn’s Disease Is Characterised by Distinct Microbiota Recolonisation , 2020, Journal of Crohn's & colitis.

[13]  T. DeSantis,et al.  Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease , 2020, Nature Communications.

[14]  F. Carneiro,et al.  Evaluation of the Use of Formalin-Fixed and Paraffin-Embedded Archive Gastric Tissues for Microbiota Characterization Using Next-Generation Sequencing , 2020, International journal of molecular sciences.

[15]  A. Amedei,et al.  Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease , 2019, Front. Immunol..

[16]  S. Mani,et al.  Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System , 2019, Microorganisms.

[17]  B. Giusti,et al.  Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: the CARDIVEG Study , 2019, European Journal of Nutrition.

[18]  H. Sokol,et al.  Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn’s disease , 2019, Gut.

[19]  J. Stelling,et al.  Microbial network disturbances in relapsing refractory Crohn’s disease , 2019, Nature Medicine.

[20]  T. Dinan,et al.  Faecal microRNAs: indicators of imbalance at the host-microbe interface? , 2017, Beneficial microbes.

[21]  J. Paul,et al.  MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients , 2017, World journal of gastroenterology.

[22]  Maria Saarela,et al.  Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response , 2017, Schizophrenia Research.

[23]  Praveen Sethupathy,et al.  Functional Transcriptomics in Diverse Intestinal Epithelial Cell Types Reveals Robust MicroRNA Sensitivity in Intestinal Stem Cells to Microbial Status* , 2017, The Journal of Biological Chemistry.

[24]  C. Huttenhower,et al.  Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease , 2016, Gut.

[25]  Eric A. Franzosa,et al.  Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans , 2016, Cell.

[26]  G. Van Domselaar,et al.  Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients , 2016, Inflammatory bowel diseases.

[27]  A. Taddei,et al.  The interplay between the microbiome and the adaptive immune response in cancer development , 2016, Therapeutic advances in gastroenterology.

[28]  J. Doré,et al.  Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery , 2015, Gut.

[29]  Li Wu,et al.  MicroRNA-223 Regulates the Differentiation and Function of Intestinal Dendritic Cells and Macrophages by Targeting C/EBPβ. , 2015, Cell reports.

[30]  D. Iliopoulos,et al.  Assessment of Circulating MicroRNAs for the Diagnosis and Disease Activity Evaluation in Patients with Ulcerative Colitis by Using the Nanostring Technology , 2015, Inflammatory bowel diseases.

[31]  R. Gold,et al.  Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. , 2015, Immunity.

[32]  Lan Liu,et al.  Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells , 2015, Molecular Cancer.

[33]  Duccio Cavalieri,et al.  MICCA: a complete and accurate software for taxonomic profiling of metagenomic data , 2015, Scientific Reports.

[34]  T. Sanchez-Elsner,et al.  MicroRNAs in Inflammatory Bowel Diseases: Paradoxes and Possibilities , 2015, Inflammatory bowel diseases.

[35]  Chris McSweeney,et al.  Association between specific mucosa‐associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: A pilot study , 2015, Journal of gastroenterology and hepatology.

[36]  A H Buck,et al.  MicroRNAs: new players in IBD , 2014, Gut.

[37]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[38]  V. Annese,et al.  Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort. , 2014, Journal of Crohn's & colitis.

[39]  J. Bunge,et al.  Estimating diversity via frequency ratios , 2014, Biometrics.

[40]  Weixu Chen,et al.  Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. , 2014, World journal of gastrointestinal pathophysiology.

[41]  P. Rutgeerts,et al.  Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD , 2014, Gut.

[42]  A. Kostic,et al.  The microbiome in inflammatory bowel disease: current status and the future ahead. , 2014, Gastroenterology.

[43]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[44]  S. Winter,et al.  Why related bacterial species bloom simultaneously in the gut: principles underlying the ‘Like will to like’ concept , 2014, Cellular microbiology.

[45]  Trevor Murrells,et al.  Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings , 2014, Gut.

[46]  J. Schreiber,et al.  MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. , 2013, The Journal of clinical investigation.

[47]  Barbara M. Bakker,et al.  The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.

[48]  J. Raisch,et al.  Role of microRNAs in the immune system, inflammation and cancer. , 2013, World journal of gastroenterology.

[49]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[50]  Zhigang Zhang,et al.  Diversified pattern of the human colorectal cancer microbiome , 2013, Gut Pathogens.

[51]  Brandi L. Cantarel,et al.  Integrated Metagenomics/Metaproteomics Reveals Human Host-Microbiota Signatures of Crohn's Disease , 2012, PloS one.

[52]  Francisco Guarner,et al.  The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.

[53]  Bas E Dutilh,et al.  A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects , 2012, Nature Reviews Microbiology.

[54]  S. Safe,et al.  A Novel Regulator of Macrophage Activation: miR-223 in Obesity-Associated Adipose Tissue Inflammation , 2012, Circulation.

[55]  Pietro Invernizzi,et al.  MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. , 2012, Autoimmunity reviews.

[56]  N. Vigneswaran,et al.  Selective Upregulation of microRNA Expression in Peripheral Blood Leukocytes in IL-10−/− Mice Precedes Expression in the Colon , 2011, The Journal of Immunology.

[57]  Liping Zhao,et al.  Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers , 2011, The ISME Journal.

[58]  Gaoxue Wang,et al.  Immunomodulatory effects of secondary metabolites from thermophilic Anoxybacillus kamchatkensis XA-1 on carp, Cyprinus carpio. , 2011, Fish & shellfish immunology.

[59]  Y. Liu,et al.  Immunostimulatory activities of specific bacterial secondary metabolite of Anoxybacillus flavithermus strain SX‐4 on carp, Cyprinus carpio , 2011, Journal of applied microbiology.

[60]  Y. Naito,et al.  Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis , 2010, Journal of gastroenterology and hepatology.

[61]  Ryan M. O’Connell,et al.  Physiological and pathological roles for microRNAs in the immune system , 2010, Nature Reviews Immunology.

[62]  Manuel A. S. Santos,et al.  MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells , 2009, Proceedings of the National Academy of Sciences.

[63]  W. Roediger.  Intestinal mycoplasma in Crohn's disease. , 2008, Novartis Foundation symposium.

[64]  J. Satsangi,et al.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.

[65]  F. Boyen,et al.  Medium-Chain Fatty Acids Decrease Colonization and Invasion through hilA Suppression Shortly after Infection of Chickens with Salmonella enterica Serovar Enteritidis , 2004, Applied and Environmental Microbiology.

[66]  G. Macfarlane,et al.  Regulation of short-chain fatty acid production , 2003, Proceedings of the Nutrition Society.

[67]  G. Hellers,et al.  Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease , 2000, The British journal of surgery.

[68]  F. Annunziato,et al.  T cells and cytokines in Crohn's disease. , 1997, Current opinion in immunology.

[69]  Eric Z. Chen,et al.  Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease. , 2017, Cell host & microbe.

[70]  Manfred Dietel,et al.  Mucosal flora in inflammatory bowel disease. , 2002, Gastroenterology.